Hiv-1 immunogenic compositions

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/21 (2006.01) A61K 39/39 (2006.01) A61P 31/18 (2006.01) A61P 37/04 (2006.01)

Patent

CA 2651764

The present invention encompasses vaccine and/or immunogenic compositions against HIV and their methods of use for the prevention and/or treatment of HIV infection and/or AIDS. The vaccine and/or immunogenic compositions may contain an isolated HTV protein or fragment thereof, an adjuvant comprising a Toll like receptor (TLR) 4 ligand, in combination with a saponin.

La présente invention concerne un vaccin et/ou des compositions immunogènes anti-VIH, ainsi que leurs procédés d'utilisation pour prévenir et/ou traiter l'infection par le VIH et/ou le SIDA. Le vaccin et/ou les compositions immunogènes peuvent contenir une protéine HTV isolée ou un fragment de celle-ci, un adjuvant comprenant un ligand de récepteur de type Toll (Toll like receptor/ TLR) 4 en combinaison avec une saponine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hiv-1 immunogenic compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hiv-1 immunogenic compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hiv-1 immunogenic compositions will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1446591

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.